跳至主要内容
临床试验/NCT00585156
NCT00585156终止早期 1 期

The Effects of Celecoxib on Bone Ingrowth in Porous Coated Titanium Ceramic Implants in Humans

University of Utah1 个研究点 分布在 1 个国家目标入组 9 人开始时间: 2008年6月最近更新:
适应症
干预措施

试验速览

阶段
早期 1 期
状态
终止
入组人数
9
试验地点
1
主要终点
Bone Ingrowth

研究概览

简要总结

The purpose of this study is to evaluate the effect of Celebrex on bone growth into porous coated implants, following postoperative total knee arthroplasty administration of Celebrex for pain relief.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 95 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Male VA bilateral TKA patients 18 years or older with primary OA diagnosis

排除标准

  • Patients with osteoporosis, hypersensitivity to Celebrex, allergy to tetracycline, Sulfonamides, patient with asthma, urticaria, or allergic-type reactions to aspirin or NSAIDs.
  • Patients who have had CABG.
  • Patients with a history of peptic ulcer disease, duodenal ulcers.
  • Female patients and patients diagnosed with unstable hypertension or hypotensive, with serum creative levels above 1.8-2.0 or diagnosed with severe renal disease.

研究组 & 干预措施

Arm #1

Experimental

Celebrex treatment group

干预措施: Celecoxib (Drug)

结局指标

主要结局

Bone Ingrowth

时间窗: 12 weeks

次要结局

  • Pain Score(10 days postoperative)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验